 |
JOURNAL TOOLS |
| Opzioni di pubblicazione |
| eTOC |
| Per abbonarsi |
| Sottometti un articolo |
| Segnala alla tua biblioteca |
ARTICLE TOOLS |
| Publication history |
| Estratti |
| Permessi |
| Per citare questo articolo |
| Share |
I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
REVIEW
Minerva Respiratory Medicine 2022 September;61(3):138-45
DOI: 10.23736/S2784-8477.22.01999-4
Copyright © 2022 EDIZIONI MINERVA MEDICA
lingua: Inglese
Paraoxonase-1 in stable chronic obstructive pulmonary disease: a systematic review and meta-analysis
Elisabetta ZINELLU 1, Angelo ZINELLU 2, Maria C. PAU 3, Alessandro G. FOIS 1, 3, Sabrina MELLINO 2, Arduino A. MANGONI 4, Ciriaco CARRU 2, Pietro PIRINA 1, 3 ✉
1 Unit of Clinical and Interventional Pulmonology, University Hospital Sassari, Sassari, Italy; 2 Department of Biomedical Sciences, University of Sassari, Sassari, Italy; 3 Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy; 4 College of Medicine and Public Health, Department of Clinical Pharmacology, Flinders Medical Center, Flinders University, Bedford Park, Australia
INTRODUCTION: Oxidative stress plays a critical pathophysiological role in chronic obstructive pulmonary disease (COPD). An impairment in antioxidant defense systems, which include the enzyme paraoxonase1 (PON-1), have been reported in COPD patients. This systematic review and meta-analysis investigated the association between serum PON1 and COPD.
EVIDENCE ACQUISITION: A systematic search was performed using the following terms and their combination: “paraoxonase-1” or “PON-1” and “chronic obstructive pulmonary disease” or “COPD” in PubMed, Web of Science, Scopus, and Google Scholar, from inception to October 2021. Standardized mean differences (SMDs) of serum PON-1 concentrations between stable COPD patients and non-COPD subjects were calculated.
EVIDENCE SYNTHESIS: Thirteen studies were included in the meta-analysis. Pooled results showed that serum PON-1 concentrations were significantly lower in patients with COPD (SMD=-1.12, 95% CI: -1.72 to -0.53; P<0.001).
CONCLUSIONS: The observed reduction of PON-1 concentrations in COPD patients supports the presence of an impaired antioxidant defense system in this group.
KEY WORDS: Pulmonary disease, chronic obstructive; Oxidative stress; Systematic review